Luye Pharma (02186.HK): Ruoxinlin Successfully Renewed for Inclusion in the National Reimbursement Drug List

Zhitong Finance APP News, Luye Pharma (02186.HK) announced that the Class 1 innovative drug Ruoxinlin (Toludesvenlafaxine Hydrochloride Extended-Release Tablets) has successfully renewed its inclusion in the "National Drug Catalog for Basic Medical Insurance, Work-Related Injury Insurance, and Maternity Insurance (2026)" (2026 National Medical Insurance Drug Catalog) for the treatment of depression.